These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6096843)

  • 1. [Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alpha-adrenergic system?].
    Rivory JP; Maheut H
    Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6096843
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis.
    Bousquet J; Rivory JP; Maheut M; Michel FB; Mion C
    J Allergy Clin Immunol; 1989 Apr; 83(4):825-8. PubMed ID: 2708742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs.
    Calvagno M
    Farmaco Prat; 1982 Jun; 37(6):200-5. PubMed ID: 7106277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
    Forette F; Varin D; Henry JF; Hervy MP
    Nouv Presse Med; 1980 Dec; 9(48):3685-8. PubMed ID: 7005872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P; Ballanger P
    J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study on nicergoline in peripheral arteriopathies.
    Schönenberger F
    Farmaco Prat; 1976 Nov; 31(11):561-7. PubMed ID: 797575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of nicergoline (Sermion) in the treatment of migraine].
    Prusiński A; Durko A; Selmaj K
    Wiad Lek; 1984 Mar; 37(6):420-2. PubMed ID: 6385484
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of nicergoline on the intellectual performance (author's transl)].
    Donoso A; Santander M; Sarce H
    Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
    Michelangeli J; Sevilla M; Lavagna J; Darcourt G
    Ann Med Psychol (Paris); 1975 Apr; 1(4):499-510. PubMed ID: 788599
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nicergoline in otorhinolaryngology].
    Pech A; Gitenet P
    Ann Otolaryngol Chir Cervicofac; 1975; 92(10-11):625-8. PubMed ID: 1211743
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
    Dauverchain J
    Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
    Kaemmerer E
    Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
    Karyofilis A
    Ther Ggw; 1980 Dec; 119(12):1478-85. PubMed ID: 7466692
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of nicergoline in acute myocardial infarction with diastolic hypertension.
    Triulzi E; Devizzi S; Margonato A
    Farmaco Prat; 1981 Oct; 36(10):449-55. PubMed ID: 7308417
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous effect of nicergoline in arterial hypertension].
    Levenson JA; Roland E; Toto Mou Kouo J; Simon A; Safar M
    Rev Med Interne; 1980; 1(1):123-6. PubMed ID: 7232904
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of nicergoline in the prevention of postoperative thrombophlebitis].
    Kauffmann JP; Keller D; Calderoli H; Ackermann E; Hollender LF
    Med Chir Dig; 1981; 10(2):169-72. PubMed ID: 7230952
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of injectable sermion in otologic diseases].
    Gaillard J; Dubreuil C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1979 Sep; 28(7):477-80. PubMed ID: 41025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nicergoline and severe isolated cranial injuries].
    Alibert F; Devaux C; Sauger F; Winckler C
    Agressologie; 1982; 23(E):93-8. PubMed ID: 7137483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.